CLPBY लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (8 May 2024 @ 01:29):

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally...

Stats
आज की मात्रा	65 552.00
औसत मात्रा	110 519
बाजार मूल्य	28.16B
EPS	$0.598 ( 2023-06-30 )
अगली कमाई की तारीख	( $0.0800 ) 2024-05-09
Last Dividend	$0.0740 ( 2023-05-19 )
Next Dividend	$0 ( N/A )
P/E	37.97
ATR14	$0.0340 (0.28%)

मात्रा सहसंबंध

लंबा: -0.05 (neutral)

छोटा: -0.81 (strong negative)

Signal:(43.774) Neutral

Coloplast A/S सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Coloplast A/S सहसंबंध - मुद्रा/वस्त्र

-0.34
( neutral )

-0.38
( neutral )

0.00
( neutral )

-0.61
( weak negative )

0.42
( neutral )

0.05
( neutral )

Coloplast A/S वित्तीय

Annual	2023
राजस्व:	$24.50B
सकल लाभ:	$16.33B (66.64 %)
EPS:	$22.21

FY	2023
राजस्व:	$24.50B
सकल लाभ:	$16.33B (66.64 %)
EPS:	$22.21

FY	2022
राजस्व:	$22.58B
सकल लाभ:	$15.53B (68.78 %)
EPS:	$22.15

FY	2021
राजस्व:	$19.43B
सकल लाभ:	$13.31B (68.53 %)
EPS:	$2.27

Financial Reports:

No articles found.

Coloplast A/S Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0.210 (N/A)	$0 (N/A)	$0.0740 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Coloplast A/S Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 6.57 - average (85.65%) | Divividend Growth Potential Score: 5.74 - Stable (14.78%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.0810	2021-05-14
Last Dividend	$0.0740	2023-05-19
Next Dividend	$0	N/A
Payout Date	2023-05-30
Next Payout Date	N/A
# dividends	5	--
Total Paid Out	$0.649	--
Avg. Dividend % Per Year	0.00%	--
Score	2.9	--
Div. Sustainability Score	6.57
Div.Growth Potential Score	5.74
Div. Directional Score	6.15	--

Next Divdend (Est)
(2024-10-01)

$0.00796 Estimate 3.61 %

Dividend Stability

0.29 Very Poor

Dividend Score

2.90

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
SHZHY	Ex Dividend Knight	2023-09-11	Semi-Annually	0.00%
FQVLF	Ex Dividend Junior	2023-08-25	Annually	0.00%
MTUAY	Ex Dividend Junior	2023-05-12	Annually	0.00%
CNBA	Ex Dividend Knight	2023-08-15	Quarterly	0.00%
TDCB	Ex Dividend Knight	2023-09-14	Quarterly	0.00%
HKMPY	Ex Dividend Knight	2023-08-11	Semi-Annually	0.00%
AMIGY	Ex Dividend Knight	2023-09-07	Semi-Annually	0.00%
OSCUF	Ex Dividend Junior	2023-09-28	Annually	0.00%
CYFL	Ex Dividend Knight	2023-09-05	Quarterly	0.00%
UEPCN	Ex Dividend Knight	2023-07-20	Quarterly	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.195	1.500	6.11	9.16	[0 - 0.5]
returnOnAssetsTTM	0.100	1.200	6.66	7.99	[0 - 0.3]
returnOnEquityTTM	0.424	1.500	6.40	9.60	[0.1 - 1]
payoutRatioTTM	0.957	-1.000	0.433	-0.433	[0 - 1]
currentRatioTTM	0.532	0.800	-2.34	-1.871	[1 - 3]
quickRatioTTM	0.324	0.800	-2.80	-2.24	[0.8 - 2.5]
cashRatioTTM	0.0484	1.500	-0.842	-1.263	[0.2 - 2]
debtRatioTTM	0.445	-1.500	2.58	-3.87	[0 - 0.6]
interestCoverageTTM	9.31	1.000	7.66	7.66	[3 - 30]
operatingCashFlowPerShareTTM	25.30	2.00	1.568	3.14	[0 - 30]
freeCashFlowPerShareTTM	19.61	2.00	0.195	0.389	[0 - 20]
debtEquityRatioTTM	1.430	-1.500	4.28	-6.42	[0 - 2.5]
grossProfitMarginTTM	0.667	1.000	2.21	2.21	[0.2 - 0.8]
operatingProfitMarginTTM	0.273	1.000	6.53	6.53	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.256	1.000	9.69	9.69	[0.2 - 2]
assetTurnoverTTM	0.515	0.800	9.90	7.92	[0.5 - 2]
Total Score				6.57

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	3.92	1.000	9.71	0	[1 - 100]
returnOnEquityTTM	0.424	2.50	7.69	9.60	[0.1 - 1.5]
freeCashFlowPerShareTTM	19.61	2.00	3.46	0.389	[0 - 30]
dividendYielPercentageTTM	0.0509	1.500	8.73	0	[0 - 0.4]
operatingCashFlowPerShareTTM	25.30	2.00	1.568	3.14	[0 - 30]
payoutRatioTTM	0.957	1.500	0.433	-0.433	[0 - 1]
pegRatioTTM	2.09	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.221	1.000	6.97	0	[0.1 - 0.5]
Total Score				5.74

Coloplast A/S

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates in three segments: Chronic Care, Interventional Urology, and Wound & Skin Care. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include bathing and cleansing products, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.

के लिए वास्तविक समय के अद्यतन Coloplast A/S [CLPBY]

Upcoming Earnings Alert

Coloplast A/S Dividend Information - Ex Dividend Junior

Dividend Commentary

Top 10 dividend Companies for OTC

Dividend Sustainability Score (DSS)

Dividend Growth Score (DGS)